middle.news
BlinkLab Elevates CEO to Managing Director Ahead of Crucial FDA Autism Trial
9:11am on Thursday 18th of December, 2025 AEDT
•
Healthcare
Read Story
BlinkLab Elevates CEO to Managing Director Ahead of Crucial FDA Autism Trial
9:11am on Thursday 18th of December, 2025 AEDT
Key Points
Dr Henk-Jan Boele promoted to Managing Director to lead FDA 510(k) trial
BlinkLab Dx 1 autism diagnostic pivotal trial set to start in Q1 2026
Non-Executive Director Jane Morgan resigns after significant contributions
Company aligns leadership with increased clinical and regulatory demands
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Blinklab (ASX:BB1)
OPEN ARTICLE